Drug Type Small molecule drug |
Synonyms SMD-3218 |
Target |
Action inhibitors |
Mechanism CGAS inhibitors(cyclic GMP-AMP synthase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Lupus Vulgaris | Preclinical | United States | 12 Oct 2022 | |
| Lupus Vulgaris | Preclinical | United States | 12 Oct 2022 | |
| Vitiligo | Preclinical | United States | 12 Oct 2022 | |
| Vitiligo | Preclinical | United States | 12 Oct 2022 |





